Percutaneous Transforaminal Endoscopic Surgery (PTES) for Treatment of Lumbar Degenerative Disease in Patients with Underlying Diseases: A Retrospective Cohort Study of 196 Cases
DOI: https://doi.org/10.2147/JPR.S396993
IF: 2.8319
2023-04-01
Journal of Pain Research
Abstract:Tianyao Zhou, 1, 2, &ast Tianle Ma, 1, 2, &ast Yutong Gu, 1, 2 Liang Zhang, 1 Wu Che, 1 Yichao Wang 1 1 Department of Orthopedic Surgery, Zhongshan Hospital Fudan University, Shanghai, 200032, People's Republic of China; 2 Shanghai Southwest Spine Surgery Center, Shanghai, 200032, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yutong Gu, Email Objective: To evaluate the postoperative outcomes, safety and feasibility of percutaneous transforaminal endoscopic surgery (PTES) for the treatment of lumbar degenerative disease (LDD) in the patients with underlying diseases. Methods: From June 2017 to April 2019, PTES was performed to treat 226 patients of single-level LDD. According to clinical background, the patients were divided into two groups. A total of 102 patients with underlying diseases were included in group A. The other 124 LDD patients without underlying diseases were included in group B. The occurrence of postoperative complications was recorded. Leg pain was assessed before, immediately, 1 month, 2 months, 3 months, 6 months, 1 year, and 2 years after PTES using VAS, and ODI before PTES and 2 years after PTES were recorded. The therapeutic quality (Excellent, Good, Moderate or Poor) was defined according to MacNab grade at 2-year follow-up. Results: No aggravation of underlying diseases or serious complications was observed in all patients within 6 months after the operation. Altogether, 196 patients were followed up for more than 2 years, 89 patients in group A and 107 patients in group B. The VAS score of leg pain and ODI dropped significantly after surgery (P< 0.001) in both groups. One case of group B received PTES again due to recurrence 52 months after surgery. According to MacNab, the excellent and good rate was 97.75% (87/89) in group A and 96.26% (103/107) in group B. In operative duration, frequency of intraoperative fluoroscopy, blood loss, incision length, hospital stay, VAS, ODI, and the excellent and good rate, there was no statistical difference between the two groups. Conclusion: PTES is safe, effective and feasible for the treatment of LDD with underlying diseases, which is comparable to PTES for LDD without underlying diseases. The entrance point of PTES (Gu's Point) is located at the corner of the flat back turning to the lateral side. PTES is not only a minimally invasive surgical technique but also includes a postoperative care system for preventing LDD recurrence. Keywords: lumbar degenerative disease, the underlying disease, transforaminal, endoscopic discectomy, minimally invasive surgery Lumbar degenerative disease (LDD) is maintaining growth within the recent years with the development of society and aging population. Conservative treatments, such as bed-resting and oral medication application, are generally firstly introduced to the patients, while surgical treatments will be subsequently considered for those patients with severe disease progression. The efficacy and safety of surgical treatment remain to be a major clinical challenge for patients suffering from underlying diseases such as vital organ failure, post-cardiac surgery, post-live or kidney transplantation, diabetes, and hypertension. So far, few studies have been reported in this field. In addition, traditional open surgical procedures also have certain disadvantages, including wide dissection of paraspinal muscles, bone structures destruction, massive blood loss, long operative duration and slow recovery. 1 Comparatively, a transforaminal endoscopic technique such as Yeung endoscopic spine surgery (YESS) and Thomas Hoogland endoscopic spine surgery (TESS), becoming a widely performed approach gradually, 2,3 shows great advantages such as smaller incision, less damage of soft tissue and bone structure, and faster recovery. 4–7 Based on a lot of practice, we successfully developed a practical and easy-handled transforaminal endoscopic technique named percutaneous transforaminal endoscopic surgery (PTES). 8–10 The surgical procedure of PTES is known as simple orientation, easy puncture, reduced steps, less fluoroscopic X-ray exposure and shorter operative duration compared with the conventional endoscopic techniques, thus providing an effective way to treat LDD. In this study, we used PTES to treat the patients of LDD with or without underlying diseases and evaluated the postoperative outcomes, safety and feasibility of PTES for the treatment of LDD in the patients with underlying diseases. From June 2017 to April 2019, PTES was performed to treat 226 single-level LDD patients in day surger -Abstract Truncated-
clinical neurology